Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

McMaster University

$25,000.00

Regulation and function of melatonin receptors

FY 2010-11

Summary
The pineal gland in mammals including humans, produces a chemical messenger or hormone called melatonin, which exhibits very low daytime levels, with peak levels present in the circulation at night. This hormone plays an important role in the regulation of circadian rhythms by interacting with the biological clock in the brain. It is also involved in modulating other brain activity, endocrine function, immune responses and reproductive activity. There is increasing evidence that melatonin can exert anticancer effects and it has been shown to inhibit the growth of human breast tumours. In addition, recent studies indicate that melatonin is a neuroprotective hormone which protects brain cells against the injurious effects of free radicals, environmental neurotoxins and other hazardous substances. In order to produce these effects, melatonin travels in the bloodstream to reach the brain and other organs, where it binds to specific sites or receptors on target cells. Melatonin binding conveys a signal to these cells, which results in a cascade of cellular responses, with consequent changes in the functional activity of the target organ. Importantly, older individuals exhibit a significant decrease in the nocturnal levels of this protective hormone, which is thought to be related to the progressive age-related onset of neurodegenerative disorders such as Parkinson's disease, Alzheimer's and other diseases including cancer. Genetic studies have identified two distinct receptors for melatonin in humans and other mammals. This proposal is aimed at clarifying how melatonin receptors are regulated by drugs or other agents and how this affects the biological effects of this hormone. This information will advance our understanding of the diverse physiological or functional roles of melatonin. Ultimately, it will be possible to utilize rational physiological approaches to harness and maintain the widespread benefits of this protective hormone, in treating or preventing various pathological conditions including neurodegeneration and cancer.
Program
Discovery Grants Program - Individual
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
1238-2009
Name nom
Niles, Lennard
Department département
Psychiatry and Behavioural Neurosciences
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2010
Competition year année de concours
2009
Award amount
25000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
32
Committee name en
Cell Biology
Committee name fr
Biologie cellulaire
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5400
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Biochemistry
Research subject fr
Biochimie
Partie
2
Nb partie
5
Application title
Regulation and function of melatonin receptors
Keyword
NSERC
Application summary
The pineal gland in mammals including humans, produces a chemical messenger or hormone called melatonin, which exhibits very low daytime levels, with peak levels present in the circulation at night. This hormone plays an important role in the regulation of circadian rhythms by interacting with the biological clock in the brain. It is also involved in modulating other brain activity, endocrine function, immune responses and reproductive activity. There is increasing evidence that melatonin can exert anticancer effects and it has been shown to inhibit the growth of human breast tumours. In addition, recent studies indicate that melatonin is a neuroprotective hormone which protects brain cells against the injurious effects of free radicals, environmental neurotoxins and other hazardous substances. In order to produce these effects, melatonin travels in the bloodstream to reach the brain and other organs, where it binds to specific sites or receptors on target cells. Melatonin binding conveys a signal to these cells, which results in a cascade of cellular responses, with consequent changes in the functional activity of the target organ. Importantly, older individuals exhibit a significant decrease in the nocturnal levels of this protective hormone, which is thought to be related to the progressive age-related onset of neurodegenerative disorders such as Parkinson's disease, Alzheimer's and other diseases including cancer. Genetic studies have identified two distinct receptors for melatonin in humans and other mammals. This proposal is aimed at clarifying how melatonin receptors are regulated by drugs or other agents and how this affects the biological effects of this hormone. This information will advance our understanding of the diverse physiological or functional roles of melatonin. Ultimately, it will be possible to utilize rational physiological approaches to harness and maintain the widespread benefits of this protective hormone, in treating or preventing various pathological conditions including neurodegeneration and cancer.